Athena Countouriotis

2.5k citations
21 papers · 1.9k indexed · 1 hit paper · h-index 14
Topics
Chronic Lymphocytic Leukemia Research (15 papers)Chronic Myeloid Leukemia Treatments (15 papers)Eosinophilic Disorders and Syndromes (11 papers)
Partner nations
United StatesItalyFrance

In The Last Decade

Athena Countouriotis

20 papers receiving 1.9k citations

Hit Papers

Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phas...20122026201620212012100200300

Peers

Athena Countouriotis
Comparison fields: 5 of 65
  • Hematology 1.6k
  • Genetics 1.4k
  • Rheumatology 943
  • Oncology 323
  • Public Health, Environmental and Occupational Health 188
Replace Albert Hoenekopp with:
Albert Hoenekopp Switzerland
Concepción Boqué Spain
Beatriz Moiraghi Argentina
Phuong Dang Australia
Philipp D. le Coutre Germany
M. Brigid Bradley‐Garelik United States
Anna Turkina Russia
Philippe Rousselot France
Ron Paquette United States
Franck E. Nicolini France
Athena Countouriotis relative to Albert Hoenekopp Switzerland Albert Hoenekopp's profile →
Citations per field
00.5×1.5×
Albert Hoenekopp · 1×
Citations per year

Countries citing papers authored by Athena Countouriotis

Since Specialization
Citations

This map shows the geographic impact of Athena Countouriotis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athena Countouriotis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athena Countouriotis more than expected).

Fields of papers citing papers by Athena Countouriotis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athena Countouriotis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athena Countouriotis. The network helps show where Athena Countouriotis may publish in the future.

Co-authorship network of co-authors of Athena Countouriotis

This figure shows the co-authorship network connecting the top 25 collaborators of Athena Countouriotis. A scholar is included among the top collaborators of Athena Countouriotis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athena Countouriotis. Athena Countouriotis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 148
2
Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trialbreakdown →
344
3 4
4 21
5 15
6 2
7 0
8 14
9 18
10 8
11 271
12 277
13 21
14 8
15 2
16 445
17 20
18 3
19 20
20 33

About Athena Countouriotis

Athena Countouriotis is a scholar working on Genetics, Hematology and Rheumatology, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (15 papers) and Eosinophilic Disorders and Syndromes (11 papers). The work is most often cited by research in Hematology (1.6k citations), Genetics (1.4k citations) and Rheumatology (943 citations). Athena Countouriotis has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Hagop M. Kantarjian, Carlo Gambacorti‐Passerini, Jörge E. Cortes, Tim H. Brümmendorf, Michele Baccarani, Timothy P. Hughes, Neil P. Shah, Dong‐Wook Kim, Karı̈n Gogat and Andreas Hochhaus. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026